Thomas Froehlich

1.1k total citations · 1 hit paper
14 papers, 821 citations indexed

About

Thomas Froehlich is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Thomas Froehlich has authored 14 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Thomas Froehlich's work include Chronic Lymphocytic Leukemia Research (2 papers), Chronic Disease Management Strategies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Thomas Froehlich is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Chronic Disease Management Strategies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Thomas Froehlich collaborates with scholars based in United States and Germany. Thomas Froehlich's co-authors include Andrew Y. Koh, Laura Coughlin, Jiwoong Kim, Eugene P. Frenkel, Arthur E. Frankel, Yang Xie, Andreas Hoeflich, Helmut J. Kolb, Georg J. Arnold and Eckhard Wolf and has published in prestigious journals such as Journal of Clinical Oncology, Endocrinology and Journal of Neuroscience Methods.

In The Last Decade

Thomas Froehlich

14 papers receiving 809 citations

Hit Papers

Metagenomic Shotgun Sequencing and Unbiased Metabolomic P... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
    2017 496 citations Arthur E. Frankel, Laura Coughlin et al. Neoplasia profile →

Peers

Thomas Froehlich
Theresa M. Guerin United States
Yuzhen Tao Canada
Myoung-Kuk Jang South Korea
Xiaoming Zou China
Amon Asgharpour United States
Nadine Gehrke Germany
Shiyun Tan China
Jasmin Schmid Ireland
Dirk Graf Germany
A. Sekine Japan
Theresa M. Guerin United States
Thomas Froehlich
Citations per year, relative to Thomas Froehlich Thomas Froehlich (= 1×) peers Theresa M. Guerin

Countries citing papers authored by Thomas Froehlich

Since Specialization
Citations

This map shows the geographic impact of Thomas Froehlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Froehlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Froehlich more than expected).

Fields of papers citing papers by Thomas Froehlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Froehlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Froehlich. The network helps show where Thomas Froehlich may publish in the future.

Co-authorship network of co-authors of Thomas Froehlich

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Froehlich. A scholar is included among the top collaborators of Thomas Froehlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Froehlich. Thomas Froehlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Haley, Barbara, Kiran Batra, Sunati Sahoo, et al.. (2021). A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy. Clinical Breast Cancer. 21(5). 417–424. 16 indexed citations
2.
Martin‐Cook, Kristin, Alexandra M Huffman, Donna Bryant, et al.. (2021). Applying Lean Six Sigma to Improve Depression Screening and Follow-Up in Oncology Clinics. Journal for Healthcare Quality. 43(3). 153–162. 2 indexed citations
3.
Fullington, Hannah, et al.. (2019). Safety and outcomes of a cancer patient urgent care clinic.. Journal of Clinical Oncology. 37(15_suppl). 6542–6542. 1 indexed citations
4.
Hong, Arthur S., et al.. (2019). Impact of a Cancer Urgent Care Clinic on Regional Emergency Department Visits. Journal of Oncology Practice. 15(6). e501–e509. 17 indexed citations
5.
Arasaratnam, Reuben J., et al.. (2018). Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy. Oncology. 95(5). 319–322. 7 indexed citations
6.
Brown, Timothy J., Nizar Bhulani, Christine Hong, et al.. (2018). Development of a nutrition-focused quality improvement program for new patients with cancer seen at the UTSW Simmons Comprehensive Cancer Center (SCCC) outpatient gastrointestinal (GI) oncology clinic.. Journal of Clinical Oncology. 36(30_suppl). 143–143. 2 indexed citations
7.
Frankel, Arthur E., Laura Coughlin, Jiwoong Kim, et al.. (2017). Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 19(10). 848–855. 496 indexed citations breakdown →
8.
Frankel, Arthur E., Uğur Eskiocak, Jennifer G. Gill, et al.. (2017). Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients. Neoplasia. 19(4). 255–260. 38 indexed citations
9.
Frankel, Arthur E., Thomas Froehlich, Jiwoong Kim, et al.. (2017). Metagenomic shotgun sequencing to identify specific human gut microbes associated with immune checkpoint therapy efficacy in melanoma patients.. Journal of Clinical Oncology. 35(15_suppl). 9516–9516. 3 indexed citations
10.
Gillardon, Frank, Elisabeth Kremmer, Thomas Froehlich, et al.. (2013). ATP-competitive LRRK2 inhibitors interfere with monoclonal antibody binding to the kinase domain of LRRK2 under native conditions. A method to directly monitor the active conformation of LRRK2?. Journal of Neuroscience Methods. 214(1). 62–68. 9 indexed citations
11.
Froehlich, Thomas, et al.. (2008). Hybridization Probe Pairs and Single-Labeled Probes: an Alternative Approach for Genotyping and Quantification. Methods in molecular biology. 429. 117–133. 5 indexed citations
12.
Froehlich, Thomas, et al.. (2006). REFLUX DETECTION WITH COMBINED ESOPHAGEAL IMPEDANCE‐PH MEASUREMENT IN CHILDREN‐FIRST DATA FROM THE GERMAN PEDIATRIC IMPEDANCE GROUP (G‐PIG). Journal of Pediatric Gastroenterology and Nutrition. 42(5). 2 indexed citations
13.
Pusch, W., et al.. (2001). genotools SNP MANAGER: A New Software for Automated High-Throughput MALDI-TOF Mass Spectrometry SNP Genotyping. BioTechniques. 30(1). 210–215. 34 indexed citations
14.
Hoeflich, Andreas, Minyao Wu, Subburaman Mohan, et al.. (1999). Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in Transgenic Mice Reduces Postnatal Body Weight Gain. Endocrinology. 140(12). 5488–5496. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa M. Guerin Breakdown of academic impact, for papers by Yuzhen Tao Breakdown of academic impact, for papers by Myoung-Kuk Jang Breakdown of academic impact, for papers by Xiaoming Zou Breakdown of academic impact, for papers by Amon Asgharpour Breakdown of academic impact, for papers by Nadine Gehrke Breakdown of academic impact, for papers by Shiyun Tan Breakdown of academic impact, for papers by Jasmin Schmid Breakdown of academic impact, for papers by Dirk Graf Breakdown of academic impact, for papers by A. Sekine
Rankless by CCL
2026